vs

Side-by-side financial comparison of CME Group (CME) and RXO, Inc. (RXO). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.5B, roughly 1.3× RXO, Inc.). CME Group runs the higher net margin — 0.1% vs -3.1%, a 3.2% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs -11.9%). Over the past eight quarters, RXO, Inc.'s revenue compounded faster (26.8% CAGR vs 10.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

RXO, Inc. is a leading transportation and logistics solutions provider headquartered in the United States. Its core service portfolio includes freight brokerage, last-mile delivery for heavy and bulky goods, managed transportation services, and end-to-end supply chain optimization support, primarily catering to clients across the North American manufacturing, retail, and e-commerce segments.

CME vs RXO — Head-to-Head

Bigger by revenue
CME
CME
1.3× larger
CME
$1.9B
$1.5B
RXO
Growing faster (revenue YoY)
CME
CME
+26.4% gap
CME
14.5%
-11.9%
RXO
Higher net margin
CME
CME
3.2% more per $
CME
0.1%
-3.1%
RXO
Faster 2-yr revenue CAGR
RXO
RXO
Annualised
RXO
26.8%
10.8%
CME

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CME
CME
RXO
RXO
Revenue
$1.9B
$1.5B
Net Profit
$1.2M
$-46.0M
Gross Margin
Operating Margin
0.1%
-2.9%
Net Margin
0.1%
-3.1%
Revenue YoY
14.5%
-11.9%
Net Profit YoY
20.7%
-84.0%
EPS (diluted)
$-0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
RXO
RXO
Q1 26
$1.9B
Q4 25
$1.6B
$1.5B
Q3 25
$1.5B
$1.4B
Q2 25
$1.7B
$1.4B
Q1 25
$1.6B
$1.4B
Q4 24
$1.5B
$1.7B
Q3 24
$1.6B
$1.0B
Q2 24
$1.5B
$930.0M
Net Profit
CME
CME
RXO
RXO
Q1 26
$1.2M
Q4 25
$1.2B
$-46.0M
Q3 25
$908.0M
$-14.0M
Q2 25
$1.0B
$-9.0M
Q1 25
$956.2M
$-31.0M
Q4 24
$874.6M
$-25.0M
Q3 24
$912.8M
$-243.0M
Q2 24
$883.2M
$-7.0M
Operating Margin
CME
CME
RXO
RXO
Q1 26
0.1%
Q4 25
61.8%
-2.9%
Q3 25
63.3%
-0.5%
Q2 25
66.7%
Q1 25
67.5%
-2.1%
Q4 24
62.1%
-1.4%
Q3 24
64.6%
-1.9%
Q2 24
65.3%
Net Margin
CME
CME
RXO
RXO
Q1 26
0.1%
Q4 25
71.7%
-3.1%
Q3 25
59.1%
-1.0%
Q2 25
60.6%
-0.6%
Q1 25
58.2%
-2.2%
Q4 24
57.3%
-1.5%
Q3 24
57.6%
-23.4%
Q2 24
57.6%
-0.8%
EPS (diluted)
CME
CME
RXO
RXO
Q1 26
Q4 25
$3.24
$-0.28
Q3 25
$2.49
$-0.08
Q2 25
$2.81
$-0.05
Q1 25
$2.62
$-0.18
Q4 24
$2.40
$-0.17
Q3 24
$2.50
$-1.81
Q2 24
$2.42
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
RXO
RXO
Cash + ST InvestmentsLiquidity on hand
$2.4B
$17.0M
Total DebtLower is stronger
$3.4B
$387.0M
Stockholders' EquityBook value
$1.5B
Total Assets
$202.0B
$3.3B
Debt / EquityLower = less leverage
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
RXO
RXO
Q1 26
$2.4B
Q4 25
$4.5B
$17.0M
Q3 25
$2.6B
$25.0M
Q2 25
$2.1B
$18.0M
Q1 25
$1.5B
$16.0M
Q4 24
$3.0B
$35.0M
Q3 24
$2.4B
$55.0M
Q2 24
$1.9B
$7.0M
Total Debt
CME
CME
RXO
RXO
Q1 26
$3.4B
Q4 25
$387.0M
Q3 25
$387.0M
Q2 25
$387.0M
Q1 25
$387.0M
Q4 24
$351.0M
Q3 24
$352.0M
Q2 24
$370.0M
Stockholders' Equity
CME
CME
RXO
RXO
Q1 26
Q4 25
$28.7B
$1.5B
Q3 25
$28.2B
$1.6B
Q2 25
$27.7B
$1.6B
Q1 25
$27.0B
$1.6B
Q4 24
$26.5B
$1.6B
Q3 24
$28.2B
$1.7B
Q2 24
$27.6B
$579.0M
Total Assets
CME
CME
RXO
RXO
Q1 26
$202.0B
Q4 25
$198.4B
$3.3B
Q3 25
$187.1B
$3.2B
Q2 25
$179.9B
$3.2B
Q1 25
$157.8B
$3.3B
Q4 24
$137.4B
$3.4B
Q3 24
$137.8B
$3.4B
Q2 24
$123.4B
$1.8B
Debt / Equity
CME
CME
RXO
RXO
Q1 26
Q4 25
0.25×
Q3 25
0.24×
Q2 25
0.24×
Q1 25
0.24×
Q4 24
0.22×
Q3 24
0.21×
Q2 24
0.64×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
RXO
RXO
Operating Cash FlowLast quarter
$7.0M
Free Cash FlowOCF − Capex
$-9.0M
FCF MarginFCF / Revenue
-0.6%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-8.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
RXO
RXO
Q1 26
Q4 25
$1.1B
$7.0M
Q3 25
$968.1M
$23.0M
Q2 25
$1.1B
$23.0M
Q1 25
$1.1B
$-2.0M
Q4 24
$1.0B
$-7.0M
Q3 24
$1.0B
$-7.0M
Q2 24
$776.9M
$-5.0M
Free Cash Flow
CME
CME
RXO
RXO
Q1 26
Q4 25
$1.1B
$-9.0M
Q3 25
$949.7M
$9.0M
Q2 25
$1.0B
$9.0M
Q1 25
$1.1B
$-17.0M
Q4 24
$991.7M
$-19.0M
Q3 24
$973.2M
$-18.0M
Q2 24
$758.7M
$-16.0M
FCF Margin
CME
CME
RXO
RXO
Q1 26
Q4 25
66.8%
-0.6%
Q3 25
61.8%
0.6%
Q2 25
61.5%
0.6%
Q1 25
67.1%
-1.2%
Q4 24
65.0%
-1.1%
Q3 24
61.4%
-1.7%
Q2 24
49.5%
-1.7%
Capex Intensity
CME
CME
RXO
RXO
Q1 26
Q4 25
2.0%
1.1%
Q3 25
1.2%
1.0%
Q2 25
1.1%
1.0%
Q1 25
0.9%
1.0%
Q4 24
1.7%
0.7%
Q3 24
1.9%
1.1%
Q2 24
1.2%
1.2%
Cash Conversion
CME
CME
RXO
RXO
Q1 26
Q4 25
0.96×
Q3 25
1.07×
Q2 25
1.03×
Q1 25
1.17×
Q4 24
1.16×
Q3 24
1.10×
Q2 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

RXO
RXO

Retail Sector$546.0M37%
Last Mile$298.0M20%
Food And Beverage Sector$225.0M15%
Other Sector$185.0M13%
Managed Transportation$133.0M9%
Automotive Sector$93.0M6%

Related Comparisons